Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)
Authors
Huang, HongyunYoung, Wise
Chen, Lin
Feng, Shiqing
Zoubi, Ziad M. Al
Sharma, Hari Shanker
Saberi, Hooshang
Moviglia, Gustavo A.
He, Xijing
Muresanu, Dafin F.
Sharma, Alok
Otom, Ali
Andrews, Russell J.
Al-Zoubi, Adeeb
Bryukhovetskiy, Andrey S.
Chernykh, Elena R.
Domańska-Janik, Krystyna
Jafar, Emad
Johnson, W. Eustace
Li, Ying
Li, Daqing
Luan, Zuo
Mao, Gengsheng
Shetty, Ashok K.
Siniscalco, Dario
Skaper, Stephen
Sun, Tiansheng
Wang, Yunliang
Wiklund, Lars
Xue, Qun
You, Si-Wei
Zheng, Zuncheng
Dimitrijevic, Milan R.
Masri, W. S. El
Sanberg, Paul R.
Xu, Qunyuan
Luan, Guoming
Chopp, Michael
Cho, Kyoung-Suok
Zhou, Xin-Fu
Wu, Ping
Liu, Kai
Mobasheri, Hamid
Ohtori, Seiji
Tanaka, Hiroyuki
Han, Fabin
Feng, Yaping
Zhang, Shaocheng
Lu, Yingjie
Zhang, Zhicheng
Rao, Yaojian
Tang, Zhouping
Xi, Haitao
Wu, Liang
Shen, Shunji
Xue, Mengzhou
Xiang, Guanghong
Guo, Xiaoling
Yang, Xiaofeng
Hao, Yujun
Hu, Yong
Li, Jinfeng
AO, Qiang
Wang, Bin
Zhang, Zhiwen
Lu, Ming
Li, Tong
Publication Date
2018-04-11
Metadata
Show full item recordAbstract
Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.Citation
Cell Transplantation, volume 27, issue 2, page 310-324Publisher
SAGE PublicationsType
articleDescription
From Crossref journal articles via Jisc Publications RouterHistory: epub 2018-04-11